Calcium plus vitamin D supplementation facilitated Fat loss in overweight and obese college students with very-low calcium consumption: a randomized controlled trial by unknown
Zhu et al. Nutrition Journal 2013, 12:8
http://www.nutritionj.com/content/12/1/8RESEARCH Open AccessCalcium plus vitamin D3 supplementation
facilitated Fat loss in overweight and obese
college students with very-low calcium
consumption: a randomized controlled trial
Wei Zhu1,2, Donglian Cai2*, Ying Wang2, Ning Lin3, Qingqing Hu2, Yang Qi2, Shuangshuang Ma2
and Sidath Amarasekara2Abstract
Background: Recent evidence suggests that higher calcium and/or vitamin D intake may be associated with lower
body weight and better metabolic health. Due to contradictory findings from intervention trials, we investigated
the effect of calcium plus vitamin D3 (calcium+D) supplementation on anthropometric and metabolic profiles
during energy restriction in healthy, overweight and obese adults with very-low calcium consumption.
Methods: Fifty-three subjects were randomly assigned in an open-label, randomized controlled trial to receive
either an energy-restricted diet (−500 kcal/d) supplemented with 600 mg elemental calcium and 125 IU vitamin D3
or energy restriction alone for 12 weeks. Repeated measurements of variance were performed to evaluate the
differences between groups for changes in body weight, BMI, body composition, waist circumference, and blood
pressures, as well as in plasma TG, TC, HDL, LDL, glucose and insulin concentrations.
Results: Eighty-one percent of participants completed the trial (85% from the calcium + D group; 78% from the
control group). A significantly greater decrease in fat mass loss was observed in the calcium + D group (−2.8±1.3
vs.-1.8±1.3 kg; P=0.02) than in the control group, although there was no significant difference in body weight
change (P>0.05) between groups. The calcium + D group also exhibited greater decrease in visceral fat mass and
visceral fat area (P<0.05 for both). No significant difference was detected for changes in metabolic variables
(P>0.05).
Conclusion: Calcium plus vitamin D3 supplementation for 12 weeks augmented body fat and visceral fat loss in
very-low calcium consumers during energy restriction.
Trial registration: ClinicalTrials.gov (NCT01447433, http://clinicaltrials.gov/).
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Dietary calcium, a non-energy-supplying nutrient, has
been identified as playing a pivotal role in the regulation
of energy and lipid metabolism [1]. Observational stud-
ies have demonstrated calcium intake is inversely asso-
ciated with body weight [2-4], dyslipidemia [1], type 2
diabetes [5] and hypertension [6]. In the same vein,* Correspondence: nutrition1226@sohu.com
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reproduction in any medium, provided the orhigher vitamin D intake and elevated level of serum 25
(OH)D have been reported to be related to lower adipos-
ity [7,8] and metabolic health [9]. However, results from
randomized controlled trials to evaluate the effect of
supplemented calcium with or without vitamin D on
weight management and metabolic profiles remain con-
troversial [10,11].
Findings from Zemel’s study of the agouti gene in
obesity and insulin resistance demonstrated that
increased intracellular calcium, resulting from a low cal-
cium diet, resulted in stimulation of lipogenic gene. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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lipolysis, thus promoting adiposity [12]. It is suggested,
however, that vitamin D deficiency increases appetite
and decreases energy consumption by stimulating
Agouti Related Protein/ Neuropeptide Y (AgRP/NPY)
and suppressing the pro-Opiomelanocortin/ Cocaine-
Amphetamine- Regulated Transcription (POMC/CART)
pathway [13].
One plausible explanation for the contradictory find-
ings could be the threshold hypothesis, suggested by
Zemel et al. and Major et al., that promising outcomes
might be predicted under the cut-off value of initial cal-
cium intake (500–600 mg/d) in a calcium supplemented
weight-loss program [10]. We initiated the current study
in subjects whose calcium consumption was below the
cutoff value, with the hypothesis that greater weight re-
duction and a better metabolic profile would be seen in
the calcium+D supplemented group than in the control
group, independent of caloric deficit.
Methods
Study design
We conducted an open-label, randomized, parallel-group
controlled trial from April to December, 2011. Recruit-
ment and screening procedures were launched in the first
6 months, after which a 12-week intervention period was
carried on.
Participants
Participants were recruited through flyers and advertise-
ments posted on college campuses in Pudong and
Yangpu Districts in Shanghai, China. A total of 129
volunteers were evaluated for eligibility. Participants of
the present study had to be generally healthy (absence of
coronary heart disease, hypertension, diabetes; dyslipide-
mia), overweight or obese (defined by a body mass index
(BMI) of 24 kg/m2 or more and 28 kg/m2 or more, re-
spectively, according to the Chinese standard [14-16]),
aged 18 to 25 years, daily calcium intake below 600 mg
(assessed with a food frequency questionnaire (FFQ)),
stable body weight (body weight change less than 1 kg
for 2 months before screening), less than 3 times per
week of 20 mins of physical exercise, no use of calcium
supplements or any medication that could affect body
weight within 30 days of screening, no smoking, ab-
sence of pregnancy or lactation, and not participating
in any weight loss programs or in any other clinical
trial within 6 months of screening. Each participant
was fully informed of the risks and benefits associated
with the study and signed written informed consent
form. All subjects were studied under protocols
approved by the Shanghai Changhai Hospital Ethnics
Committee (CHEC2011-020). This study was registered
on ClinicalTrials.gov. (NCT01447433).Randomization and interventions
A total of 53 subjects were randomly assigned with a 1:1
allocation to either calcium+D (n=26) or control group
(n=27). Randomization was computer-generated, and a
randomization sequence was created using SPSS 13.0 for
windows (SPSS Inc., Chicago, USA). Stratified ran-
domization was adopted when allocating 7 male sub-
jects, with 3 allocated to calcium+D and 4 to the control
group. The calcium+D group received 600 mg of cal-
cium carbonate plus 125 IU vitamin D3 (purchased from
the primary agent of Caltrate in Shanghai, China), admi-
nistered as the dose of one tablet taken daily after
breakfast.
In addition, both groups received 500 kcal/d of caloric
deficit. Total daily energy expenditure (TDEE) of each
subject was calculated using World Health Organization
equations for calculation of basal metabolic rate (BMR),
and was estimated as 1.3×BMR for obese individuals
engaged in mild daily activity [14]. Based on this initial
estimate of energy needs, a standard recipe of a balanced
diet (protein 10~15% of total energy supply, fat 20~30%,
carbohydrates 55~65%) was created to produce a daily
caloric deficit of 500 kcal. Each participant received a
standard recipe and a portion-size picture booklet of
food models of common foods and measuring containers
for their self-monitoring of daily food intake. Nutritional
supplements were not permitted. Dietary instruction and
counseling were provided to subjects in both groups
during biweekly follow-ups throughout the program.
Assessment
A semiquantitative FFQ [15] was used for each partici-
pant during screening with 149 items in 17 food categor-
ies, including rice, wheat flour, other cereals, potatoes,
pork, poultry, fish, eggs, milk, legumes and their pro-
ducts, fresh vegetables, salted vegetables, fresh fruits,
vegetable oil, nuts, salt, soy sauce and liquor. An average
portion size for each item was specified, and subjects
were asked about the frequency of consuming that unit
throughout the previous year. Dietary records were ana-
lyzed, using the Nutrition Calculator Software (version
2.3, developed by the Chinese Center for Disease Con-
trol and Prevention [CDC]). Only those whose initial
calcium intake was below 600 mg entered further
screening procedures.
Prior to randomization, participants received a phys-
ical examination, including body weight, height, body
composition, blood pressure and blood chemistry. Those
who met the inclusion and exclusion criteria entered the
program. All of the anthropometric measurements and
blood chemistry tests were repeated at the end of 12-wk
intervention, while body composition was obtained at
4-wk intervals. All the assessments were obtained using
standard protocols.
Zhu et al. Nutrition Journal 2013, 12:8 Page 3 of 8
http://www.nutritionj.com/content/12/1/8Anthropometric variables and blood samples were
obtained between 8:00 and 10:00 a.m. after an overnight
fast. Subjects were asked to void their bladders before
measurement and to wear light clothes. Height was mea-
sured barefoot using a stadiometer to the nearest 0.1 cm
and weight was obtained to the nearest 0.1 kg using a
digital scale. BMI was calculated as weight (kg)/ height
(m)2. Waist circumference were measured using plastic
tape to the nearest 0.1 cm. Systolic and diastolic blood
pressures were measured in the left arm at heart level
with subjects seated for a minimum of 5 minutes using
mercurial sphygmomanometer. The measurement was
repeated once so as to take the mean value. Bioelectric
impedance analysis (BIA, ZEUS 9.9, JAWON) was used
to determine body fat mass, fat percentage, and lean
mass, as well as visceral fat mass and visceral fat area
(VFA). Blood samples were collected and sent to the clin-
ical laboratory of Changhai Hospital within 30 min.
Plasma glucose was measured enzymatically. Plasma insu-
lin was assayed using an Electrochemiluminescence Im-
munoassay Kit (Roche Diagnostics GmbH, Manneheim,
Germany). Total cholesterol and triglyceride (TC and TG)
and high- and low-density lipoprotein (HDL and LDL)
concentrations were measured using an automated en-
zymatic analyzer (Automatic Analyzer 7080, Hitachi,
Tokyo, Japan).
Participants were required to submit 3-day food
records at baseline and after 12 weeks. As most of the
subjects took their meals at the students’ canteen, where
the amount of each dish of food was approximately
fixed, we asked them to record the amount of staple
food consumed and the portion of the leftover of each
dish containing animal or plant foods. The dietitian
made a detailed list of each dish of food in advance. Sub-
jects were also asked to record their consumption of
fruits, snacks, beverages, etc. Each diet record was care-
fully reviewed and analyzed by a registered dietitian.
Dietary records were analyzed using the Nutrition Cal-
culator Software for energy, protein, fat, carbohydrate
and calcium intakes. During the whole period, subjects
were required to maintain the same calcium intake as
assessed by the initial FFQ. Compliance for total energy
and dietary calcium intake were monitored throughout
the program while guidance was given to subjects that
had trouble following our dietary instructions. Calcium
+D tablets were issued at baseline, exchanged for a new
package at wk 4 and wk 8, and returned for counting for
compliance, which was 95.8% in the calcium+D group,
at the conclusion of the intervention.
Statistical analysis
Statistical analysis was performed by using SPSS 13.0 for
windows (SPSS Inc., Chicago, USA). Independent t-test
between means and chi-square test for frequencies wereused to assess differences between groups in baseline
characteristics of subjects. Repeated measures of vari-
ance were performed to evaluate the significance of the
differences between groups for changes on outcome
variables. All data were presented as mean ± standard
deviation. P<0.05 was considered significant.
Results
The sample size in both groups was adequate in the
present study. We needed a total of 42 participants to
detect a 1.5 kg difference in 12 weeks in weight change
between groups with 90% power at the 0.05 level. We
increased the sample size to 26 per group to allow for
dropouts with 20% attrition. A total of 43 subjects com-
pleted the trial. Ten dropped out after enrollment: 2 lost
contact (both from the control group); 6 withdrew for
personal reasons (3 from each group; one dropped out
of college, one left for another city for internship, and
four lost interest) ; and 2 were excluded for poor compli-
ance (one from the control group that refused to follow
our dietary instructions, the other from the calcium+D
group for less than 90% adherence by tablet counts at
week 8). No adverse event was reported throughout the
study. All of the 43 subjects were included in final ana-
lysis (Figure 1).
Baseline characteristics of subjects are shown in
Table 1. No significant difference was observed in base-
line characteristics between groups. Table 2 indicated
anthropometric and metabolic variables at baseline and
after 12 weeks, as well as changes in these variables be-
tween measurement periods. As expected, both groups
achieved significant reduction in anthropometric vari-
ables during the 12-wk program in the context of energy
restriction. Significant time×treatment effects were
observed for changes in body fat mass, fat percentage,
visceral fat mass and VFA (P<0.05 for all), in which the
difference between groups remained significant even
after adjustment for age, gender, initial calcium intake
and baseline body weight. A significantly greater de-
crease in fat mass loss was observed in the calcium + D
group (−2.8±1.3 vs.-1.8±1.3 kg; P=0.02), which was
55.6% higher than in the control group, although there
was no significant difference in body weight change
(P>0.05) between groups. Subjects in the calcium + D
group also exhibited greater decrease in visceral fat mass
and VFA (P=0.01 and P=0.02, respectively). No signifi-
cant difference was detected for changes between groups
in lean mass, waist circumference, or blood pressure, or
in plasma TG, TC, HDL, LDL, glucose and insulin con-
centrations (P>0.05 for all). Table 3 showed body com-
position changes of subjects between baseline and wk 4,
wk 8, and wk 12 on the basis of the intention-to-treat
(ITT) analysis. As illustrated in Table 3, the calcium + D
group witnessed significantly greater reduction in fat
Enrollment
Assessed for eligibility (n=129)
Excluded (n=76)
Declined to participate: 9
Initial calcium intake 600 mg/d: 34
BMI 24 kg/m2: 16
Used calcium supplements: 3
Be on a diet: 14
At wk 4 (n=26); at wk 8 (n=25); at wk 12  (n=22)
Discontinued participation (n=4)
Lost to follow-up: 0
Withdraw by subject: 3
Protocol violation: 1
Allocated to calcium D group (n=26)
(Received energy restriction and 
supplementation of calcium D)
At wk 4 (n=25); at wk 8 (n=23); at wk 12  (n=21)
Discontinued participation (n=6)
Lost to follow-up: 2
Withdraw by subject: 3
Protocol violation: 1
Allocated to control group (n=27)




Excluded from analysis (n=0)
Included in analysis (n=22)
Excluded from analysis (n=0)
Included in analysis (n=21)
Analysis
Figure 1 Study flow diagram.
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and wk 12 (P<0.05 for all), compared with the control
group.
Energy and nutrient intake at baseline were not signifi-
cantly different between groups. At the end of the study,
the estimated daily intake of energy was significantly lower












Habitual Calcium Intake (mg/d) 426.5±152.2
Calcium+D, Calcium+Vitamin D3. BMI, body mass index. VFA, visceral fat area.
a Independent t-test between means.
b Mean ± standard deviation (all such values).
c Overweight was defined as BMI from 24 to 27.9 kg/m2, and obesity was defined agroup and −307.9±298.2 kcal in the control group).
Changes in percentage of energy from protein, fat and car-
bohydrates were 0.9±2.2%, - 1.9±3.9%, and 1.0±5.2%,
respectively, in the calcium + D group and −0.1±2.3%, -
0.3±4.7%, and 4.4±5.5%, respectively, in the control group.
No significant difference was found in all these dietary
changes between groups (P>0.05 for all). Dietary calciumControl Group P a
(n=21)
20.3±0.8 0.50









s BMI≥28 kg/m2 [14-16].
Table 2 Anthropometric and metabolic variables before and after intervention in variables throughout the study
Calcium+D (n=22) Control (n=21) P a
Pre Post Pre Post Time Treatment Time×Treatment (adjusted b)
Body weight (kg) 65.7±7.6 c 61.5±7.2 66.3±8.3 62.8±9.7 <0.001 0.69 0.25 (0.16)
BMI (kg/m2) 26.0±1.8 24.2±1.8 25.7±1.7 24.2±2.2 <0.001 0.86 0.22 (0.19)
Fat mass (kg) 20.4±3.3 17.6±3.5 19.8±3.1 17.9±3.9 <0.001 0.73 0.02 (0.01)
Fat percentage (%) 31.0±3.0 28.4±3.5 29.9±2.8 28.4±3.0 <0.001 0.55 0.02 (0.02)
Lean mass (kg) 41.6±5.2 40.5±4.5 42.8±5.9 41.3±6.2 <0.001 0.54 0.31 (0.43)
Visceral fat mass (kg) d 2.2±0.5 1.7±0.4 2.1±0.5 1.9±0.6 <0.001 0.75 0.01 (0.01)
VFA (cm2) d 56.6±12.2 44.6±12.6 54.7±13.4 48.2±15.5 <0.001 0.85 0.02 (0.02)
Waist (cm) 81.5±4.1 75.2±5.3 80.9±5.6 76.3±6.8 <0.001 0.85 0.34 (0.26)
Systolic BP (mmHg) d 119.2±10.5 109.6±9.9 123.0±10.5 111.9±10.4 <0.001 0.20 0.64 (0.67)
Diastolic BP (mmHg) d 70.7±7.1 64.2±4.7 70.0±7.8 65.4±6.3 0.001 0.79 0.58 (0.62)
Glucose (mmol/L) 4.62±0.26 4.89±0.37 4.55±0.34 4.91±0.31 <0.001 0.96 0.22 (0.16)
Insulin (mIU/L) 10.49±5.04 9.24±5.36 9.07±4.02 9.23±4.62 0.58 0.52 0.44 (0.41)
TC (mmol/L) 3.89±0.52 3.78±0.61 4.11±0.43 3.93±0.48 0.03 0.58 0.57 (0.42)
TG (mmol/L) 0.76±0.48 0.78±0.25 0.76±0.32 0.86±0.67 0.36 0.75 0.61 (0.61)
HDL (mmol/L) 1.49±0.39 1.59±0.36 1.66±0.34 1.51±0.30 0.22 0.53 0.11 (0.19)
LDL (mmol/L) 1.89±0.50 2.41±0.43 1.98±0.50 2.10±0.51 0.23 0.43 0.62 (0.75)
Calcium+D, Calcium+vitamin D3. VFA, visceral fat area. Waist, waist circumference BP, blood pressure. TC, total cholesterol. TG, triglyceride. HDL, high-density
lipoproteins. LDL, low-density lipoproteins. Change values=[(mean values wk 12)-(mean values wk 0)].
a Repeated measures analysis of variance.
b Adjusted for age, initial calcium intake and baseline body weight.
c Mean ± standard deviation (all such values).
d n=20 and 19 for Calcium+D and control groups, respectively.
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significantly in both groups.
Discussion
In the present study, we observed that calcium+D sup-
plementation for 12 weeks facilitated fat loss in very-low
calcium consumers independent of energy restriction,
which is concordant with other randomized controlled
trials [14,16-20], suggesting a beneficial effect of calcium
intake on weight management.Table 3 Body composition changes between baseline and wk
Δ1(wk0 ~ wk 4)
Calcium+D Control P a Calciu
(n=26) (n=25) (n=2
Body weight (kg) −2.2±1.4 b 1.7±1.2 0.16 −3.3±
Fat mass (kg) −1.7±1.7 −1.0±1.1 0.13 −2.4±
Fat percentage (%) −1.6±2.5 −0.8±1.3 0.19 −2.1±
Lean mass (kg) −0.4±1.0 −0.5±1.2 0.77 −0.8±
Visceral fat mass (kg) c −0.3±0.3 −0.1±0.2 0.09 −0.4±
VFA (cm2) c −6.6±7.6 −2.9±6.6 0.12 −10.9
Calcium+D, Calcium+vitamin D3 group. Control, control group. VFA, visceral fat area
Δ1=[(mean values wk 4)-(mean values wk 0)]. Δ2=[(mean values wk 8)-(mean values
a The P-value was calculated by independent t-test between means.
b Mean ± standard deviation (all such values).
c n=24 in both groups between wk 0 and wk4; n=23 and 22 for Calcium+D and con
and control groups, respectively, between wk 0 and wk12.To our knowledge, ours is among the few relevant
studies to evaluate the effect of combined calcium and
vitamin D3 administration in very-low calcium consu-
mers by setting initial calcium intake at <600 mg/day as
one of the inclusion criteria. The mean initial calcium
intake of subjects was estimated to be 409.7 mg/day,
below the threshold previously suggested [10] to predict
promising outcomes of a weight-loss program. Previously
published studies were carried out mostly in Western
countries, where recruitment of participants with very-low4, wk 8, and wk 12
Δ2 (wk0 ~ wk 8) Δ3 (wk0 ~ wk 12)
m+D Control P Calcium+D Control P
5) (n=23) (n=22) (n=21)
1.6 3.3±1.4 0.94 −4.1±1.8 −3.5±1.9 0.25
1.2 −1.7±0.8 0.03 −2.8±1.3 −1.8±1.3 0.02
1.2 −1.1±0.9 <0.01 −2.6±1.6 −1.4±1.5 0.02
0.9 −1.2±1.7 0.24 −1.1±1.1 −1.4±1.2 0.31
0.3 −0.2±0.2 <0.01 −0.5±0.2 −0.3±0.2 0.01
±7.2 −4.6±4.9 <0.01 −12.0±6.4 −6.5±7.2 0.02
.
wk 0)]. Δ3=[(mean values wk 12)-(mean values wk 0)].
trol groups, respectively, between wk 0 and wk8; n=20 and 19 for Calcium+D
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level of calcium intake among the majority of Western
populations: 856 mg/day for men and 670 mg/day for
women in American adults; moreover, half of them use cal-
cium supplements [21]. Whereas in the Chinese popula-
tion, the average intake of calcium was around 390 mg/day,
according to the Chinese National Nutrition and Health
survey in 2002 [22]. Therefore, this population provides a
stable sample of very-low calcium consumers for investi-
gating the potential anti-adiposity effect of calcium below
the cut-off value of 600 mg/day. As expected, we observed
significant augmentation of body fat loss and visceral fat
loss in the calcium and vitamin D3 supplemented group
after the intervention. In contrast, a 24-month trial [23]
found no significant difference in anthropometric vari-
ables between the calcium-supplemented group and pla-
cebo in subjects with initial calcium intake of 882 mg/d.
Neither did Manios et al. [24] or Wagner et al. [25]
observed any beneficial effect of calcium (with or without
vitamin D) on weight management in subjects with over
650 mg/day of initial calcium intake, which constitutes
one explanation for the inconsistency. The dosage used in
calcium-supplemented programs was diverse. Zemel and
his group [17] detected a beneficial effect of calcium car-
bonate, an additional 800 mg/day, on weight reduction,
which was increased by 26% compared with the control
subjects. In Faghih’s study [19], supplementation of
800 mg/day was also found to be effective in facilitating
weight loss. Major et al. [16] reported a significantly
greater decrease in body weight and fat mass in the cal-
cium+D group (5.8 vs. 1.4 kg and 4.7 vs. 1.2 kg, respect-
ively), receiving 1200 mg calcium carbonate and 400 IU
vitamin D daily. In the present study, however, the dose
was administered as one tablet (600 mg calcium carbon-
ate, 125 IU vitamin D) daily. We used a relatively lower
dose because the initial calcium intake in the majority of
Chinese is low. In most relevant studies carried out in
Western populations the average calcium intake was
around 600 to 800 mg/d (even higher in some studies),
and the dose was about 1.5 times the initial calcium in-
take. And therefore, in the current study, the additional
600 mg/d was administered in subjects with initial cal-
cium intake of around 400 mg/d. Besides, 125 IU of vita-
min D3, which is linked with 600 mg of calcium in each
tablet, was administered in the present study, since it is an
over-the-counter supplement.
The current study recruited obese and overweight sub-
jects with a lower body mass index (BMI) cutoff, which
was believed to be required for Chinese population
[26,27], who has a lower baseline BMI to begin with and
the risk of cardiovascular diseases is doubled at BMI of
23.0 to 24.9, and tripled at BMI of 25.0 to 26.9 [28]. In
addition, we recruited subjects aged 18 to 25 years from
colleges, because these students usually had similardietary patterns and their compliance with dietary
instructions was fairly good. This made it possible for us
to evaluate the potential difference between an energy-
restricted diet with calcium+D supplementation and
energy restriction alone in a short period of 12 weeks.
Actually, the compliance to the weight loss program was
very good, since at the end of the study, subjects in both
groups achieved 5~6% of body weight reduction, sug-
gesting they were motivated by the intervention. In fact,
reported energy intake was significantly lower in both
groups at endpoint versus baseline. It is worth mentioning
that the calcium+D group achieved 55.6% augmentation
of fat mass loss compared with the control, despite the
fact that there was no significant difference in body weight
change between groups. That means the calcium+D group
lost more adipose tissue during energy restriction.
The greater decrease in fat mass observed in the
calcium+D group of the current study could result from
several factors attributing to calcium metabolism. First, a
calcium-rich diet is shown to increase fat oxidation [29],
promote fat cell apoptosis [10], and reduce lipid absorption
due to the formation of insoluble calcium-fatty acid soaps
in the intestine, which are eventually excreted in the feces
[30]. Second, high dietary calcium intake is associated with
suppression of 1,25-dihydroxyvitamin D (1,25-(OH)2D)
levels which in turn act to decrease calcium influx into the
cell. These modifications consequently stimulate lipolysis
and inhibit lipogenesis in the adipocyte [10,14]. Third, a
calcium-specific appetite control, proposed by Tordoff,
could have played a role in facilitating fat loss in a calcium-
supplemented program [16].
Moreover, the findings of the current study are con-
cordant with the majority of previously published clin-
ical trials showing no significant differences between
treatment and control subjects in glucose and insulin
profiles [31] and in circulating lipids and lipoprotein
concentrations [32-34]. There is only one previous study
[35] reporting a significantly greater decreases in total:
LDL, LDL:HDL (P<0.01 for both) and LDL cholesterol
(P<0.05) after 15 weeks of intervention in the active
group, receiving a supplementation of 1200 mg/day cal-
cium and 400 IU vitamin D and a caloric deficit of
700 kcal/day, than in the placebo group, receiving
700 kcal/day of energy restriction alone. In addition, the
present study showed no significant impact of additional
elemental calcium+D on blood pressures. It seems that
the antihypertensive effect of calcium may be more pro-
nounced with dairy-derived calcium [36,37] than elem-
ental calcium [32,34]. The former was examined in
studies that carried out over short terms (5 weeks to
16 weeks), while the latter was used in moderate or
long-term studies (6 months and 2 years). If that is the
case, it is not surprising that we did not find any signifi-
cant changes in blood pressure in such a short term.
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bioactive peptides in dairy, which act as angiotensin con-
verting enzyme inhibitors [38], may also explain the antihy-
pertensive effect in intervention trials. It will be interesting
to conduct further research on the whey-derived bioactive
peptides for blood pressure management.
The primary limitation of our study is that participants
in the control group were not given a placebo due to
budget constraints. However, in the present study the
dietitians, supervising and giving dietary instructions to
subjects, were not involved in any other procedures such
as randomization allocation or evaluation of outcome
measurements. Subjects in the present study made no
communications with each other for their participation
is confidential and individual. In addition, we avoided
reporting any subjective measurements, such as hunger
scores, as well, so as to minimize bias that could occur in
an open-label trial. Not using dual energy X-ray absorpti-
ometry (DEXA), the gold standard method for assessing
body composition, constitutes another limitation. How-
ever, BIA is also a validated and reliable method to assess
body composition [13,39]. Other limitations include the
primarily female composition of the study sample, the
relatively small dose of vitamin D3 used. From a statistical
perspective, the beneficial effects of calcium+D supple-
mentation on fat loss could be attribute to calcium as
much as to vitamin D3. However, previously published
literature tends to attribute a large contribution to calcium
instead of vitamin D due to the controversial results and
lack of evidence of the effect of vitamin D on adiposity
[35]. Future research in this area should be oriented to-
ward a better understanding of the dose–response effect
of calcium supplementation (with or without vitamin D)
on weight management by administering different dosages
of this mineral.Conclusions
To summarize, our results showed supplementation of
calcium plus vitamin D3 for 12 weeks facilitated body fat
and visceral fat loss during energy restriction in over-
weight or obese very-low calcium consumers.Abbreviations
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